Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hodgkin's disease in developing countries].

B Belgadi1, H Eghbali, B Hoerni

  • 1Fondation Bergonié, Bordeaux, France.

Bulletin Du Cancer
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic value of EndoPredict test in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative primary breast cancer screened for the randomized, double-blind, phase III UNIRAD trial.

ESMO open·2024
Same author

Cryopreservation, semen use and the likelihood of fatherhood in male Hodgkin lymphoma survivors: an EORTC-GELA Lymphoma Group cohort study.

Human reproduction (Oxford, England)·2013
Same author

Characterization of porous silicon integrated in liquid chromatography chips.

Lab on a chip·2009
Same author

[Management of 315neutropenic febrile episodes in a cancer center].

Medecine et maladies infectieuses·2008
Same author

Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials.

Annals of oncology : official journal of the European Society for Medical Oncology·2006
Same journal

Real-world outcomes and management of endometrial cancer in France from 2016 to 2021 (MOONBEAM study).

Bulletin du cancer·2026
Same journal

[Cardiotoxicity in children and adolescents with acute leukemia: Recommendations from the Leukemia Committee of the French Society of Childhood Cancer (SFCE)].

Bulletin du cancer·2026
Same journal

[Reirradiation: A new therapeutic paradigm in oncology].

Bulletin du cancer·2026
Same journal

[Robotics in oncological surgery].

Bulletin du cancer·2026
Same journal

[Robot-assisted surgery for thyroid cancer].

Bulletin du cancer·2026
Same journal

[Attractiveness of the clinical hematology specialty in France: A cross-sectional perspective from medical students, residents, and practicing hematologists].

Bulletin du cancer·2026
See all related articles

Hodgkin's disease (HD) presents differently worldwide, often being more severe in developing nations due to delayed diagnosis and advanced stages. Improving patient outcomes requires multidisciplinary care centers to manage this potentially curable cancer effectively.

Area of Science:

  • Oncology
  • Public Health

Context:

  • Hodgkin's disease (HD) exhibits distinct clinical presentations between Western and developing countries.
  • Delayed diagnosis and advanced disease stages contribute to HD's severity in developing nations.
  • Younger patient populations are disproportionately affected in these regions.

Purpose:

  • To highlight the disparities in Hodgkin's disease presentation and outcomes.
  • To emphasize the need for improved diagnostic and treatment strategies in resource-limited settings.
  • To advocate for the establishment of multidisciplinary centers for optimal cancer care.

Summary:

  • Hodgkin's disease (HD) is a significant health challenge in developing countries, characterized by late diagnosis and unfavorable pathology.
  • Despite treatment challenges, oncologists must strive to manage potentially curable cases to preserve patients' quality of life.

Related Experiment Videos

  • The management of HD can serve as a model for developing integrated, multidisciplinary cancer care centers.

    • Impact:

    • Potential to improve Hodgkin's disease survival rates in developing countries.
    • Promotes the adoption of standardized, evidence-based cancer treatment protocols.
    • Establishes a framework for multidisciplinary collaboration in oncology care.